New gene-editing tools for blood cancers

In recent years, medical health has received increasing public attention, and practices in related fields are continuing to be strongly promoted. Experts in the industry remind that scientific awareness and rational treatment are important prerequisites for good results. At the same time, strengthening health education and raising public awareness is always a work that needs long-term adherence.

According to Physicists' Network on May 31, scientists at the University of Florida in the United States have developed a new, CRISPR-based method of non-invasive blood detection, known as EXTRA-CRISPR, that is effective in the diagnosis of cancer in response to the commonly used retroviral quantitative polymerase chain, and that can be used in conjunction with a simple portable device that is expected to greatly accelerate the process of early cancer diagnosis.